Biology subjects

Kauer, J. A.

Publications and source records attributed to Kauer, J. A..

9 recordsLinked to original sources

bioRxiv2026

Cell-type targeted CRISPR/Cas9 Clock knockdown in mouse VTA dopamine neurons alter sleep, behavior, and cellular excitability

Bipolar disorder (BD) is a severe psychiatric disease characterized by recurrent mania, depression, and circadian rhythm disruption. Among circadian regulators implicated in mood-related dysfunction, Clock has emerged as a particularly strong mechanistic candidate. However, cell type-specific functions of Clock within mood-relevant circuits remain incompletely defined. Here, we developed and applied a Cre-dependent AAV-SaCas9 gene-editing strategy to disrupt Clock selectively in ventral tegmental area dopamine neurons. We first established a rapid in vitro screening pipeline for guide RNA selection that accurately predicted in vivo editing efficiency. We then targeted Clock in vivo using a single AAV-based editing strategy and observed robust titer-dependent reduction of Clock expression, by targeted sequencing, in situ hybridization, and immunohistochemistry. We assessed the functional consequences of Clock disruption across analysis levels, including a behavioral battery, circadian and sleep-wake measurements using EEG and EMG, and electrophysiological recordings. These results establish a practical framework for rapid, cell-type-specific disruption of candidate psychiatric risk genes and provide a mechanistically grounded model for investigating how loss of Clock function in mesolimbic dopaminergic circuits contributes to BD-relevant phenotypes.

neuroscience↗

bioRxiv2026

Cholecystokinin released somatodendritically from dopamine neurons broadly alters synaptic strength across the ventral tegmental area

Neuropeptides are found in nearly every brain neuron, and can modulate behaviors by regulating neuronal excitability, synaptic transmission, and plasticity. In contrast to the canonical view of neuropeptide release from nerve terminals, we previously reported the somatodendritic release of cholecystokinin (CCK) from ventral tegmental area (VTA) dopamine (DA) neurons. Release of CCK occurs during modest depolarization of VTA DA cells, and by activating CCK2Rs, potentiates synaptic transmission from GABAergic afferents. Here, recording from dopamine neurons in acute midbrain slices from male and female mice, we examined how somatodendritic release of CCK regulates synaptic plasticity and the extent of its influence. Depolarization of a dopamine neuron induced long-term potentiation (LTP) at GABAergic synapses, and in parallel somatodendritic CCK release produced long-term depression (LTD) at glutamatergic synapses. CCK-induced LTP persisted when postsynaptic G protein signaling in dopamine neurons was blocked, suggesting that CCK likely acts at GABAergic presynaptic terminals. Activation of kappa opioid receptors prevented CCK-dependent LTP of GABAergic synapses, indicating interaction between these two neuromodulatory signaling pathways in VTA. Surprisingly, depolarization of one dopamine neuron potentiated synapses onto both the depolarized neuron and neighboring dopamine neurons located up to [~]100 {micro}m away, indicating substantial spread of CCK signaling and synaptic modulation within the VTA region. Taken together, our findings demonstrate that somatodendritic CCK release bidirectionally coordinates synaptic strength across dopamine neurons, identifying a peptide-mediated feedback mechanism that shapes VTA circuit function. Significance StatementDopamine neurons in the ventral tegmental area (VTA) play central roles in reward, motivation, stress responses, and feeding behavior. While fast synaptic inputs regulate dopamine neuron firing on fast timescales, less is known about how slower neuromodulatory signals shape these circuits. We show that somatodendritic release of the neuropeptide cholecystokinin from dopamine neurons coordinately alters both inhibitory and excitatory synaptic strength and influences neighboring neurons within the VTA. This peptide-mediated feedback mechanism operates over a broader spatial scale than classical synaptic transmission and is regulated by kappa opioid signaling. These findings reveal how local peptide release can reshape dopamine circuit function and may contribute to changes in reward processing and feeding behavior.

neuroscience↗

bioRxiv2025

Kappa opioid receptors control a stress-sensitive brain circuit and drive cocaine seeking

Stress is a potent trigger for drug-seeking behaviors in both rodents and humans with a history of substance use. Kappa opioid receptors (kORs) play a critical role in mediating stress responses. Our previous studies in the ventral tegmental area (VTA) demonstrated that acute stress activates kORs to block long-term potentiation at GABAA synapses on dopamine neurons (LTPGABA) and triggers stress-induced reinstatement of cocaine seeking. Here we identify the specific GABAergic afferents affected by stress, the precise localization of kORs within the VTA, and show that VTA kOR activation is sufficient to drive reinstatement. We optogenetically activated specific GABAergic afferents and found that nucleus accumbens (NAc)-to-VTA, but not lateral hypothalamus (LH)-to-VTA projections, exhibit stress-sensitive LTPGABA. Using a conditional knock-out approach, we found that selectively deleting kORs from NAc neurons but not from dopamine cells prevents stress-induced block of LTPGABA. Selectively activating dynorphin-containing NAc neurons with an excitatory DREADD mimics acute stress, preventing LTPGABA at VTA synapses. We furthermore demonstrated that without acute stress, microinjection of a selective kOR agonist directly into the VTA facilitates cocaine reinstatement without similarly affecting sucrose-motivated responding, demonstrating the critical role of kORs in stress-induced cocaine reinstatement. Our results show that kORs on GABAergic NAc nerve terminals in the VTA underlie loss of LTPGABA that may drive stress-induced addiction-related behaviors. Our work highlights the importance of inhibitory inputs for controlling dopamine neuron excitability in the context of addiction and contributes to defining the circuit involved in stress-induced drug reinstatement.

neuroscience↗

bioRxiv2024

Loss of mitochondrial enzyme GPT2 leads to reprogramming of synaptic glutamate metabolism

Recessive loss-of-function mutations in the mitochondrial enzyme Glutamate Pyruvate Transaminase 2 (GPT2) cause intellectual disability in children. Given this cognitive disorder, and because glutamate metabolism is tightly regulated to sustain excitatory neurotransmission, here we investigate the role of GPT2 in synaptic function. GPT2 catalyzes a reversible reaction interconverting glutamate and pyruvate with alanine and alpha-ketoglutarate, a TCA cycle intermediate; thereby, GPT2 may play an important role in linking mitochondrial tricarboxylic acid (TCA) cycle with synaptic transmission. In mouse brain, we find that GPT2 is enriched in mitochondria of synaptosomes (isolated synaptic terminals). Loss of Gpt2 in mouse appears to lead to reprogramming of glutamate and glutamine metabolism, and to decreased glutamatergic synaptic transmission. Whole-cell patch-clamp recordings in pyramidal neurons of CA1 hippocampal slices from Gpt2-null mice reveal decreased excitatory post-synaptic currents (mEPSCs) without changes in mEPSC frequency, or importantly, changes in inhibitory post-synaptic currents (mIPSCs). Additional evidence of defective glutamate release included reduced levels of glutamate released from Gpt2-null synaptosomes measured biochemically. Glutamate release from synaptosomes was rescued to wild-type levels by alpha-ketoglutarate supplementation. Additionally, we observed evidence of altered metabolism in isolated Gpt2-null synaptosomes: decreased TCA cycle intermediates, and increased glutamate dehydrogenase activity. Notably, alterations in the TCA cycle and the glutamine pool were alleviated by alpha-ketoglutarate supplementation. In conclusion, our data support a model whereby GPT2 mitochondrial activity may contribute to glutamate availability in pre-synaptic terminals, thereby highlighting potential interactions between pre-synaptic mitochondrial metabolism and synaptic transmission.

neuroscience↗

bioRxiv2024

Sex-Specific Roles of Hypocretin Receptor Signaling in CRF Neurons on Alcohol Drinking, Anxiety, and BNST Neuronal Excitability

Alcohol use disorder (AUD) is characterized by compulsive alcohol consumption and negative emotional states during withdrawal, often perpetuating a cycle of addiction through arousal dysfunction. The hypocretin/orexin (Hcrt) neuropeptide system, a key regulator of arousal, has been implicated in these processes, particularly in its interactions with corticotropin-releasing factor (CRF) neurons within the bed nucleus of the stria terminalis (BNST). We investigated the role of Hcrt receptor signaling in CRF neurons in modulating alcohol intake, anxiety behaviors, and BNST excitability, with a focus on sex-specific differences. Using CRF-specific genetic deletion of HcrtR1 and/or HcrtR2 receptors in mice, we found that deletion of HcrtR1 significantly reduced alcohol intake, with sex-specific effects on BNST excitability. CRF-specific HcrtR2 deletion, while not affecting alcohol consumption, decreased baseline anxiety-like behaviors in males relative to females. Moreover, the double deletion of both Hcrt receptors from CRF neurons led to reduced alcohol drinking in males and dampened anxiety behaviors and BNST excitability in both sexes during protracted withdrawal. These findings suggest that Hcrt signaling in CRF neurons plays a critical role in the persistence of excessive alcohol consumption and the development of negative affective states, with distinct contributions from HcrtR1 and HcrtR2. The observed sex-specific differences underscore the need for tailored therapeutic approaches targeting the Hcrt system in the treatment of AUD.

neuroscience↗

bioRxiv2024

Aging and injury drive neuronal senescence in the dorsal root ganglia

Aging negatively impacts central nervous system function; however, the cellular impact of aging in the peripheral nervous system remains poorly understood. Aged individuals are more likely to experience increased pain and slower recovery after trauma. Such injury can damage vulnerable peripheral axons of dorsal root ganglion (DRG) neurons resulting in somatosensory dysfunction. One cellular mechanism common to both aging and injury is cellular senescence, a complex cell state that can contribute to the aged pro-inflammatory environment. We uncovered, for the first time, DRG neuron senescence in the context of aging and pain-inducing peripheral nerve injury in young and aged mice. Aged DRG neurons displayed multiple markers of senescence (SA-{beta}-gal, p21, p16, IL6) when compared to young DRG neurons. Peripheral nerve injury triggered a further accumulation of senescent DRG neurons over time post-injury in young and aged DRG. These senescent neurons were dynamic and heterogeneous in their expression of senescence markers, p16, p21, and senescence-associated secretory phenotype (SASP) expression of IL6, which was influenced by age. An electrophysiological characterization of senescence marker-expressing neurons revealed high-firing and nociceptor-like phenotypes within these populations. In addition, we observed improvement in nociceptive behaviors in young and aged nerve-injured mice after treatment with a senolytic agent that eliminates senescent cells. Finally, we confirmed in human post-mortem DRG samples that neuronal senescence is present and increases with age. Overall, we describe a susceptibility of the peripheral nervous system to neuronal senescence with age or injury that may be a targetable mechanism to treat sensory dysfunction, such as chronic pain, particularly in aged populations.

neuroscience↗

bioRxiv2022

Somatodendritic release of cholecystokinin potentiates GABAergic synapses onto ventral tegmental area dopamine cells

Neuropeptides are contained in nearly every neuron in the central nervous system and can be released from somatodendritic sites as well as from nerve terminals. Cholecystokinin (CCK), among the most abundant neuropeptides in the brain, is expressed in the majority of midbrain dopamine neurons. Here we report that ventral tegmental area (VTA) dopamine neurons release CCK from somatodendritic regions, where it triggers long-term potentiation of GABAergic synapses. The somatodendritic release occurs with trains of action potentials or prolonged but modest depolarization and is dependent on synaptotagmin 7 and T-type Ca2+ channels. Depolarization-induced LTP is blocked by the CCK2R antagonist, LY225910, and mimicked by exogenously added CCK. To test the behavioral role of CCK, we infused it into the mouse VTA. Ca2+ imaging in vivo demonstrated that infused CCK reduced dopamine cell signals during fasted food consumption. Moreover, local infusion of CCK also inhibited food consumption and decreased distance traveled in an open field test. Together our experiments introduce somatodendritic neuropeptide release as a previously unknown feedback regulator of VTA dopamine cell excitability and dopamine-related behaviors.

neuroscience↗

bioRxiv2021

Selective Control of Synaptically-Connected Circuit Elements by All-Optical Synapses

Understanding percepts, engrams and actions requires methods for selectively modulating synaptic communication between specific subsets of interconnected cells. Here, we develop an approach to control synaptically connected elements using bioluminescent light: Luciferase-generated light, originating from a presynaptic axon terminal, modulates an opsin in its postsynaptic target. Vesicular-localized luciferase is released into the synaptic cleft in response to presynaptic activity, creating a real-time Optical Synapse. Light production is under experimenter-control by introduction of the small molecule luciferin. Signal transmission across this optical synapse is temporally defined by the presence of both the luciferin and presynaptic activity. We validate synaptic Interluminescence by multi-electrode recording in cultured neurons and in mice in vivo. Interluminescence represents a powerful approach to achieve synapse-specific and activity-dependent circuit control during behavior in vivo.

neuroscience↗

bioRxiv2019

NMDA receptor activation induces long-term potentiation of glycine synapses

Of the fast ionotropic synapses, glycinergic synapses are the least well understood, but are vital for the maintenance of inhibitory signaling in the brain and spinal cord. Glycinergic signaling comprises half of the inhibitory signaling in the spinal cord, and glycinergic synapses are likely to regulate local nociceptive processing as well as the transmission to the brain of peripheral nociceptive information. Here we have investigated the rapid and prolonged potentiation of glycinergic synapses in the superficial dorsal horn of young male and female mice after brief activation of NMDA receptors (NMDARs). Glycinergic inhibitory postsynaptic currents (IPSCs) evoked with lamina II-III stimulation in identified GABAergic neurons in lamina II were potentiated by bath-applied Zn2+ and were depressed by the prostaglandin PGE2, consistent with the presence of both GlyR1- and GlyR3-containing receptors. NMDA application rapidly potentiated synaptic glycinergic currents. Whole-cell currents evoked by exogenous glycine were also rapidly potentiated by NMDA, indicating that the potentiation results from altered numbers or conductance of postsynaptic glycine receptors. Repetitive depolarization alone of the postsynaptic GABAergic neuron also potentiated glycinergic synapses, and intracellular EGTA prevented both NMDA-induced and depolarization-induced potentiation of glycinergic IPSCs. Driving trpv1 lineage afferents optogenetically also triggered NMDAR-dependent potentiation of glycinergic synapses. Our results suggest that during peripheral injury or inflammation, nociceptor firing during injury is likely to potentiate glycinergic synapses on GABAergic neurons. This disinhibition mechanism may be engaged rapidly, altering dorsal horn circuitry to promote the transmission of nociceptive information to the brain.\n\nSignificanceOf the fast ionotropic synapses, glycinergic synapses are the least well understood, yet glycinergic synapses comprise half of the inhibition in the spinal cord, and are likely to regulate local nociceptive processing as well as the transmission to the brain of peripheral nociceptive information. Here we report that bath applied NMDA, repetitive postsynaptic depolarization, or optogenetic activation of primary nociceptor afferents all produce LTP at superficial dorsal horn synapses. During peripheral injury or inflammation, nociceptor firing is likely to engage this mechanism in inhibitory neurons, rapidly altering dorsal horn circuitry to promote the transmission of nociceptive information to the brain.

neuroscience↗